DARE BIOSCIENCE, INC. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/01041815-43b8-49e6-90b7-1ed6d49f8be2/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.0M | 2025-01-01 – 2025-12-31 | evidence 0001401914-26-000004 |
| FY 2024 | $9.8k | 2024-01-01 – 2024-12-31 | evidence 0001401914-25-000012 |
| FY 2023 | $2.8M | 2023-01-01 – 2023-12-31 | evidence 0001401914-25-000012 |
| FY 2022 | $10.0M | 2022-01-01 – 2022-12-31 | evidence 0001401914-24-000016 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001401914-23-000013 |
| FY 2016 | $766.0k | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-005798 |
| FY 2014 | $80.0k | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001834 |
| FY 2013 | $1.7M | 2005-11-28 – 2014-03-31 | evidence 0001193125-14-212644 |
| FY 2012 | $625.0k | 2012-01-01 – 2012-12-31 | evidence 0001564590-15-001834 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
DARE BIOSCIENCE, INC. — all facts · Net Income · Operating Income